Semaglutide, a medication originally designed to treat type 2 diabetes, has recently gained significant attention as a weight ...

The talks on drugs including Novo Nordisk's Wegovy, GSK's Trelegy Ellipta, and Pfizer's Xtandi will set Medicare prices that ...

People who stayed on a 7.2 milligram weekly dose of semaglutide lost around 20% of their body weight over 72 weeks.

Ozempic was one of the 15 drugs selected for the 2027 Medicare drug price negotiation program three days before ...